Anti-platelet Therapy Clinical Trial
Official title:
Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey
Coronary Artery Disease (CAD) is leading cause of death worldwide. Most of them underwent coronary angiography and they have to use dual anti-platelet therapy. As mentioned novel guidelines for CAD, the estimated number of patients requiring dual anti-platelet therapy has increased over time, and DAPT time is controversial. Acting on the behalf of 2017 ESC focused update on dual anti-platelet therapy in coronary artery disease developed in collaboration with EACTS guideline, this study is amid to determine PRECISE-DAPT score which predicts out of hospital bleeding risk in patients receiving dual anti-platelet treatment and to detect the prevalence of patients with high bleeding risk, and to determine DAPT score which predicts benefit/risk ratio of continuing or discontinuing dual ant-iplatelet therapy after 12 months and to detect the prevalence of patients with high ischemic or hemorrhagic complication risk in centers included in this study.
Design
The study is a national, multicenter, non-interventional, observational, prospective
registry.
Population
Patients older than 18 years old of age, have acute coronary syndrome or percutaneous
coronary intervention electively and with available admission hemoglobin, white blood cell
and creatine clearance data will be enrolled for Precise-DAPT,and Patients older than 18
years old of age and completed 12 months of dual anti-platelet therapy without having
hemorrhage and ischemic coronary event and with available data of age, history of smoking,
presence of diabetes mellitus, history of percutaneous coronary intervention, paclitaxel
eluting stent, stent diameter, history of myocardial infarction, saphenous vein graft
intervention, ejection fraction or presence of heart failure. Patients that do not approve
informed consent will be excluded.
Aim
This study is amid to investigate the demographic and clinical profile of patients with CAD
and on dual anti-platelet therapy, mean precise -DAPT and DAPT scores of Turkey.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03908593 -
Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG
|
Phase 4 | |
Terminated |
NCT01810276 -
Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury
|
N/A | |
Completed |
NCT01647568 -
Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study
|
N/A |